Skip to main content

Table 2 Expected adverse events (AE), frequency and relief or treatment

From: Brain‐oscillation-synchronized stimulation to enhance motor recovery in early subacute stroke: a randomized controlled double‐blind three‐ arm parallel‐group exploratory trial comparing personalized, non‐ personalized and sham repetitive transcranial magnetic stimulation (Acronym: BOSS-STROKE)

AE

Likelihood of occurrence

Relief/ Treatment

Prevention

Seizure

Very low

rTMS halt, treatment according to neurological emergency standards

Monitoring by EEG during rTMS

Slight/moderate Headache

High

usually subside spontaneously, standard analgesics (NSAIDs)

Not applicable

Hearing impaired

Very low

rTMS halt, treatment according to otolaryngology emergency standards

patients and treatment providers will be protected by earplugs

Syncope

Low

rTMS halt, treatment according to neurological emergency standards

Monitoring by EEG during rTMS

Presyncope

Low

rTMS halted, treatment according to neurological emergency standards

Monitoring by EEG during rTMS

slight/moderate (Local) Pain

High

usually subside spontaneously, standard analgesics (NSAIDs)

Not applicable

Dizziness

Low

rTMS halt

Not applicable